Research has demonstrated that inhibiting Hh signaling using GANT61 (Gli-inhibitor) decreases PD-L1 expression and tumor proliferation, but increases the infiltration of CD8+ CTLs both in vivo in a gastric cancer mouse model, and in vitro in gastric cancer patient-derived organoid cultures [52,53]. The gene discussed is CD8A; the disease is gastric cancer.